Team L&M In a groundbreaking leap for sickle cell disease (SCD) care in India, the country is simultaneously pushing the frontiers of high-tech gene therapy and rolling out ultra-affordable diagnostic tools, as part of its ambitious mission to eliminate the disease by 2047. Gene Therapy Enters Indian Labs For decades, treatment for sickle cell anaemia […]Read More
